Gestational methylazoxymethanol exposure leads to NMDAR dysfunction in hippocampus during early development and lasting deficits in learning

Neuropsychopharmacology

Volumn 38, Issue 2, 2013, Pages 328-340

  Snyder, Melissa A ^a   Adelman, Alicia E ^a   Gao, Wen Jun ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

animal model; glutamate; hippocampus; neurodevelopment; schizophrenia

Indexed keywords

METHYLAZOXYMETHANOL; METHYLAZOXYMETHANOL ACETATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

ADOLESCENT; AFTERHYPERPOLARIZATION; AMNESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; LATENT PERIOD; LEARNING DISORDER; LOCOMOTION; LONG TERM POTENTIATION; MEMBRANE STEADY POTENTIAL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSIS; RAT; STRATUM RADIATUM; SYNAPTIC MEMBRANE;

AGE FACTORS; ANIMALS; FEMALE; HIPPOCAMPUS; LEARNING; MEMORY DISORDERS; METHYLAZOXYMETHANOL ACETATE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84871421914     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.180     Document Type: Article

References (88)

1. Akashi K, Kakizaki T, Kamiya H, Fukaya M, Yamasaki M, Abe M et al (2009). NMDA receptor GluN2B (GluR epsilon 2/NR2B) subunit is crucial for channel function, postsynaptic macro-molecular organization, and actin cytoskeleton at hippocampal CA3 synapses. J Neurosci 29: 10869-10882.
2. Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP et al (1996). Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 16: 19-30.
3. Belforte JE, Zsiros V, Sklar ER, Jiang Z, Yu G, Li Y et al (2010). Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 13: 76-83.
4. Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA (1990). Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res 35: 1-13.
5. Brigman JL, Wright T, Talani G, Prasad-Mulcare S, Jinde S, Seabold GK et al (2010). Loss of GluN2B-containing NMDA Receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning. J Neurosci 30: 4590-4600.
6. Cavus I, Reinhart RM, Roach BJ, Gueorguieva R, Teyler TJ, Clapp WC et al (2012). Impaired visual cortical plasticity in schizophrenia. Biol Psychiatry 71: 512-520.
7. Cerqueira JJ, Mailliet F, Almeida OF, Jay TM, Sousa N (2007). The prefrontal cortex as a key target of the maladaptive response to stress. J Neurosci 27: 2781-2787.
8. Coyle JT (2006). Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 26: 365-384.
9. Crain B, Cotman C, Taylor D, Lynch G (1973). A quantitative electron microscopic study of synaptogenesis in the dentate gyrus of the rat. Brain Res 63: 195-204.
10. Cull-Candy S, Brickley S, Farrant M (2001). NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11: 327-335.
11. Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE et al (1998). Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393: 377-381.
12. Dracheva S, Marras SAE, Elhakem SL, Kramer FR, Davis KL, Haroutunian V (2001). N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry 158: 1400-1410.
13. Duffy S, Labrie V, Roder JC (2008). D-Serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning. Neuropsychopharmacol 33: 1004-1018.
14. Dumas TC (2005). Developmental regulation of cognitive abilities: modified composition of a molecular switch turns on associative learning. Prog Neurobiol 76: 189-211.
15. Featherstone RE, Burton CL, Coppa-Hopman R, Rizos Z, Sinyard J, Kapur S et al (2009). Gestational treatment with methylazox-ymethanol (MAM) that disrupts hippocampal-dependent memory does not alter behavioural response to cocaine. Pharmacol Biochem Behav 93: 382-390.
16. Fink CC, Bayer KU, Myers JW, Ferrell JE Jr., Schulman H, Meyer T (2003). Selective regulation of neurite extension and synapse formation by the beta but not the alpha isoform of CaMKII. Neuron 39: 283-297.
17. Flagstad P, Glenthoj BY, Didriksen M (2005). Cognitive deficits caused by late gestational disruption of neurogenesis in rats: a preclinical model of schizophrenia. Neuropsychopharmacology 30: 250-260.
18. Flagstad P, Mork A, Glenthoj BY, van Beek J, Michael-Titus AT, Didriksen M (2004). Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens. Neuropsycho-pharmacology 29: 2052-2064.
19. Folley BS, Astur R, Jagannathan K, Calhoun VD, Pearlson GD (2010). Anomalous neural circuit function in schizophrenia during a virtual Morris water task. Neuroimage 49: 3373-3384.
20. Gambrill AC, Barria A (2011). NMDA receptor subunit composition controls synaptogenesis and synapse stabilization. Proc Natl Acad Sci USA 108: 5855-5860.
21. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA (2000). Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry 157: 1141-1149.
22. Goto Y, Grace AA (2006). Alterations in medial prefrontal cortical activity and plasticity in rats with disruption of cortical development. Biol Psychiatry 60: 1259-1267.
23. Gourevitch R, Rocher C, Le Pen G, Krebs MO, Jay TM (2004). Working memory deficits in adult rats after prenatal disruption of neurogenesis. Behav Pharmacol 15: 287-292.
24. Grace AA (2012). Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia. Neuropharmacology 62: 1342-1348.
25. Gray JA, Shi Y, Usui H, During Matthew J, Sakimura K, Nicoll Roger A (2011). Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo. Neuron 71: 1085-1101.
26. Gunduz-Bruce H (2009). The acute effects of NMDA antagonism: from the rodent to the human brain. Brain Res Rev 60: 279-286.
27. Harrison PJ (2004). The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 174: 151-162.
28. Hazane F, Krebs MO, Jay TM, Le Pen G (2009). Behavioral perturbations after prenatal neurogenesis disturbance in female rat. Neurotox Res 15: 311-320.
29. Henseler I, Falkai P, Gruber O (2010). Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms. J Psychiatr Res 44: 364-372.
30. Henson MA, Roberts AC, Perez-Otano I, Philpot BD (2010). Influence of the NR3A subunit on NMDA receptor functions. Prog Neurobiol 91: 23-37.
31. Henson MA, Roberts AC, Salimi K, Vadlamudi S, Hamer RM, Gilmore JH et al (2008). Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex. Cereb Cortex 18: 2560-2573.
32. Hradetzky E, Sanderson TM, Tsang TM, Sherwood JL, Fitzjohn SM, Lakics V et al (2012). The Methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus. Neuropsychopharmacology 37: 364-377.
33. Hsia AY, Malenka RC, Nicoll RA (1998). Development of excitatory circuitry in the hippocampus. J Neurophysiol 79: 2013-2024.
34. Javitt DC (2004). Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry 9: 984-997.
35. Kantrowitz JT, Javitt DC (2010). N-methyl-D-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull 83: 108-121.
36. Kristiansen LV, Huerta I, Beneyto M, Meador-Woodruff JH (2007). NMDA receptors and schizophrenia. Curr Opin Pharmacol 7: 48-55.
37. Larsen RS, Corlew RJ, Henson MA, Roberts AC, Mishina M, Watanabe M et al (2011). NR3A-containing NMDARs promote neurotransmitter release and spike timing-dependent plasticity. Nat Neurosci 14: 338-344.
38. Lau CG, Zukin RS (2007). NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8: 413-426.
39. Le Pen G, Gourevitch R, Hazane F, Hoareau C, Jay TM, Krebs MO (2006). Peri-pubertal maturation after developmental disturbance: a model for psychosis onset in the rat. Neuroscience 143: 395-405.
40. Lee Y-S, Silva AJ (2009). The molecular and cellular biology of enhanced cognition. Nat Rev Neurosci 10: 126-140.
41. Lewis DA, Levitt P (2002). Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25: 409-432.
42. Lipska BK, Aultman JM, Verma A, Weinberger DR, Moghaddam B (2002a). Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology 27: 47-54.
43. Lipska BK, Weinberger DR (2002b). A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus. Neurotox Res 4: 469-475.
44. Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S et al (2008). Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 31: 234-242.
45. Liu XB, Murray KD, Jones EG (2004). Switching of NMDA receptor 2A and 2B subunits at thalamic and cortical synapses during early postnatal development. J Neurosci 24: 8885-8895.
46. Lodge DJ, Behrens MM, Grace AA (2009). A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci 29: 2344-2354.
47. Lodge DJ, Grace AA (2007). Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J Neurosci 27: 11424-11430.
48. Meador-Woodruff JH, Clinton SM, Beneyto M, McCullumsmith RE (2003). Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia. Ann N Y Acad Sci 1003: 75-93.
49. Medoff DR, Holcomb HH, Lahti AC, Tamminga CA (2001). Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus 11: 543-550.
50. Mogensen J, Wortwein G, Gustafson B, Ermens P (1995). L-nitroarginine reduces hippocampal mediation of place learning in the rat. Neurobiol Learn Mem 64: 17-24.
51. Moghaddam B, Jackson ME (2003). Glutamatergic animal models of schizophrenia. Ann N Y Acad Sci 1003: 131-137.
52. Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999). Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98: 427-436.
53. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994). Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12: 529-540.
54. Moore H, Jentsch JD, Ghajarnia M, Geyer MA, Grace AA (2006). A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol Psychiatry 60: 253-264.
55. Morris RG, Anderson E, Lynch GS, Baudry M (1986). Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319: 774-776.
56. Ohno T, Maeda H, Murabe N, Kamiyama T, Yoshioka N, Mishina M et al (2010). Specific involvement of postsynaptic GluN2B-containing NMDA receptors in the developmental elimination of corticospinal synapses. Proc Natl Acad Sci USA 107: 15252-15257.
57. Okamoto K-I, Narayanan R, Lee SH, Murata K, Hayashi Y (2007). The role of CaMKII as an F-actin-bundling protein crucial for maintenance of dendritic spine structure. PNAS 104: 6418-6423.
58. Olney JW, Newcomer JW, Farber NB (1999). NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33: 523-533.
59. Perez-Otano I, Lujan R, Tavalin SJ, Plomann M, Modregger J, Liu X-B et al (2006). Endocytosis and synaptic removal of NR3A-containing NMDA receptors by PACSIN1/syndapin1. Nat Neurosci 9: 611-621.
60. Perez-Otano I, Schulteis CT, Contractor A, Lipton SA, Trimmer JS, Sucher NJ et al (2001). Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J Neurosci 21: 1228-1237.
61. Pokorny J, Yamamoto T (1981). Postnatal ontogenesis of hippocampal CA1 area in rats. I. Development of dendritic arborisation in pyramidal neurons. Brain Res Bull 7: 113-120.
62. Riekkinen M, Riekkinen P Jr. (1997). Dorsal hippocampal muscarinic acetylcholine and NMDA receptors disrupt water maze navigation. Neuroreport 8: 645-648.
63. Roberts AC, D́iez-Garćia J, Rodriguiz RM, López IP, Luján R, Mart́inez-Turrillas R et al (2009). Downregulation of NR3A-containing NMDARs is required for synapse maturation and memory consolidation. Neuron 63: 342-356.
64. Sanderson TM, Cotel MC, O'Neill MJ, Tricklebank MD, Collin-gridge GL, Sher E (2012). Alterations in hippocampal excitability, synaptic transmission and synaptic plasticity in a neurodevelopmental model of schizophrenia. Neuropharmacol-ogy 62: 1349-1358.
65. Sasaki YF, Rothe T, Premkumar LS, Das S, Cui J, Talantova MV et al (2002). Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J Neurophysiol 87: 2052-2063.
66. Sheng M, Cummings J, Roldan LA, Jan YN, Jan LY (1994). Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368: 144-147.
67. Sigurdsson T, Stark KL, Karayiorgou M, Gogos JA, Gordon JA (2010). Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 464: 763-767.
68. Silva AJ, Rosahl TW, Chapman PF, Marowitz Z, Friedman E, Frankland PW et al (1996). Impaired learning in mice with abnormal short-lived plasticity. Curr Biol 6: 1509-1518.
69. Spear LP (2000). The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24: 417-463.
70. Stoneham ET, Sanders EM, Sanyal M, Dumas TC (2010). Rules of engagement: factors that regulate activity-dependent synaptic plasticity during neural network development. Biol Bull 219: 81-99.
71. Swann JW, Smith KL, Brady RJ (1991). Age-dependent alterations in the operations of hippocampal neural networks. Ann N Y Acad Sci 627: 264-276.
72. Tamminga C (1999). Glutamatergic aspects of schizophrenia. Br J Psychiatry Suppl 37: 12-15.
73. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M et al (1999). Genetic enhancement of learning and memory in mice. Nature 401: 63-69.
74. Tong G, Takahashi H, Tu S, Shin Y, Talantova M, Zago W et al (2008). Modulation of NMDA receptor properties and synaptic transmission by the NR3A subunit in mouse hippocampal and cerebrocortical neurons. J Neurophysiol 99: 122-132.
75. Tseng KY, Lewis BL, Hashimoto T, Sesack SR, Kloc M, Lewis DA et al (2008). A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons. J Neurosci 28: 12691-12699.
76. Tsien JZ, Huerta PT, Tonegawa S (1996). The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87: 1327-1338.
77. Valenzuela-Harrington M, Gruart A, Delgado-Garcia JM (2007). Contribution of NMDA receptor NR2B subunit to synaptic plasticity during associative learning in behaving rats. Eur J Neurosci 25: 830-836.
78. von Engelhardt J, Doganci B, Jensen V, Hvalby Ø, Göngrich C, Taylor A et al (2008). Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks. Neuron 60: 846-860.
79. Wang C-C, Held Richard G, Chang S-C, Yang L, Delpire E, Ghosh A et al (2011). A critical role for GluN2B-containing NMDA receptors in cortical development and function. Neuron 72: 789-805.
80. Wang HX, Gao WJ (2009). Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex. Neuropsychopharmacol 34: 2028-2040.
81. Wang HX, Gao WJ (2010). Development of calcium-permeable AMPA receptors and their correlation with NMDA receptors in fast-spiking interneurons of rat prefrontal cortex. J Physiol 588: 2823-2838.
82. Wang HX, GGr Stradtman, Wang XJ, Gao WJ (2008). A specialized NMDA receptor function in layer 5 recurrent microcircuitry of the adult rat prefrontal cortex. Proc Natl Acad Sci USA 105: 16791-16796.
83. Williams K, Russell SL, Shen YM, Molinoff PB (1993). Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron 10: 267-278.
84. Witthaus H, Kaufmann C, Bohner G, Ozgurdal S, Gudlowski Y, Gallinat J et al (2009). Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls. Psychiatry Res 173: 163-169.
85. Xi D, Li Y-C, Snyder MA, Gao RY, Adelman AE, Zhang W et al (2011). Group II metabotropic glutamate receptor agonist ameliorates MK-801-induced dysfunction of NMDA receptors via Akt/GSK-3beta pathway. Neuropsychopharmacol 36: 1260-1274.
86. Yashiro K, Philpot BD (2008). Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity. Neuropharmacology 55: 1081-1094.
87. Zhao M-G, Toyoda H, Lee Y-S, Wu L-J, Ko SW, Zhang X-H et al (2005). Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. Neuron 47: 859-872.
88. Zhou Y, Takahashi E, Li W, Halt A, Wiltgen B, Ehninger D et al (2007). Interactions between the NR2B receptor and CaMKII modulate synaptic slasticity and spatial learning. J Neurosci 27: 13843-13853.